Table 3. Selection table for future irradiation experiments.

The summarized parameters shoulp help to decide which tumour entity is appropriate for the particular experiment. The secondary tumours were most often found a few weeks after injection at the ear base and were histologically confirmed to be of the same origin as the primary tumours, whereas the genesis could not be resolved definitely (see section 3.5).

	FaDu	LN229
After injection
Take rate	> 95%
Projectable start of treatment	14.5 ± 0.8 days	23.4 ± 1.0 days*
During experiment
Allocation rate	74%	89%
VDT	2–4 days	9–12 days
Beam loss or delay	Time shift problematic	Shift of 1 day possible
Recommended dose range	< 8 Gy	< 14 Gy
After experiment campaign
Follow up	120 days	180 days
Secondary tumours	~ 20%, fast growing	~ 8%, slowly growing

*Sometimes difficult to define, since LN229 tumours will be reddish, not red.